Metraipolis › archive › dc_41ee758e7517
Functional Suitability Evaluation of Radioimmunoconjugates of Nanobodies against PD-L1 and HER2/neu for Tumor Theranostics — Europe PMC PMID:42146863
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42146863
- DOI
- 10.17691/stm2026.18.2.03
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T23:53:32.007Z
- SHA-256 of the archived text
f53b9366d0f07c71cfac70dd3f20255408ddb702bbb796ecf783ecfe237ebdba- Stable URL of this page
https://metraipolis.com/documento/dc_41ee758e7517
How to cite
Functional Suitability Evaluation of Radioimmunoconjugates of Nanobodies against PD-L1 and HER2/neu for Tumor Theranostics — Europe PMC PMID:42146863 — Europe PMC (en), https://europepmc.org/article/MED/42146863 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_41ee758e7517 (Metraipolis archive dc_41ee758e7517, sha256 f53b9366d0f07c71cfac70dd3f20255408ddb702bbb796ecf783ecfe237ebdba)
BibTeX
@misc{dc41ee758e7517,
title = {Functional Suitability Evaluation of Radioimmunoconjugates of Nanobodies against PD-L1 and HER2/neu for Tumor Theranostics — Europe PMC PMID:42146863},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42146863},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_41ee758e7517; sha256 f53b9366d0f07c71cfac70dd3f20255408ddb702bbb796ecf783ecfe237ebdba},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42146863. Agents can read the archived copy with the MCP tool read_document.